1. P148 JAK-inhibition by baricitinib and tofacitinib ameliorates pathological bone loss. (March 2019) Authors: Adam, S; Simon, N; Steffen, U; Andes, F; Müller, D; Culemann, S; Andreev, D; Hahn, M; Scholtysek, C; Schett, G; Krönke, G; Frey, S; Hueber, A Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P149/O06 Higher expression of siglec-7/9 on granulocytes and monocytes has a protective role in rheumatoid arthritis. (March 2019) Authors: Andes, F; Zapf, J; Hahn, J; Manger, B; Schett, G; Steffen, U Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗